Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Resonance Health Ltd ( (AU:RHT) ) has issued an update.
Resonance Health Ltd has received a net cash refund of $732,851 from the Australian Taxation Office, representing the balance of its FY2025 research and development tax incentive of $832,959 after offsetting $100,108 in income tax payable. The refund strengthens the company’s cash position and supports its ongoing development of MRI-based medical imaging products and clinical trial services, underpinning its role as a specialist provider of non-invasive, AI-enabled diagnostic tools for liver and cardiac conditions.
The additional cash will be reflected in the company’s March 2026 quarterly cash flow and activities report and is likely to assist funding of its pipeline projects, including MRI-based liver fibrosis assessment and expansion of its clinical trials operations. This inflow may enhance Resonance Health’s financial flexibility as it competes in the global market for advanced imaging diagnostics used by clinicians and drug developers, potentially benefiting customers and shareholders by supporting further product innovation and service capability.
The most recent analyst rating on (AU:RHT) stock is a Hold with a A$0.04 price target. To see the full list of analyst forecasts on Resonance Health Ltd stock, see the AU:RHT Stock Forecast page.
More about Resonance Health Ltd
Resonance Health Ltd is an Australian healthcare technology and services company whose products are used globally by clinicians and pharmaceutical and therapeutic companies in managing human diseases and supporting clinical trials. It specialises in quantitative MRI-based Software-as-Medical Devices, including AI-enabled tools such as FerriScan, FerriSmart, HepaFatScan, HepaFatSmart, LiverSmart and CardiacT2*, and operates a clinical trials business in Australia.
Average Trading Volume: 323,427
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$19.08M
See more data about RHT stock on TipRanks’ Stock Analysis page.